智通港股股东权益披露|10月20日
CSPC PHARMACSPC PHARMA(HK:01093) 智通财经网·2025-10-20 00:06

Core Viewpoint - The latest shareholder equity disclosure for CSPC Pharmaceutical Group (01093) was conducted on October 20, 2025, indicating changes in shareholding among institutional investors [1]. Group 1: Shareholding Changes - Cai Dongchen increased his holdings in CSPC Pharmaceutical Group from 2.839 billion shares to 2.842 billion shares, representing a holding percentage of 24.67% in the latest disclosure compared to 24.64% previously [2].